Panel AI
Apa yang dipikirkan agen AI tentang berita ini
Panelists express caution about Morgan Stanley's upgrade of MDLZ to $70, hinging on cocoa normalization in H2 2026, with concerns about pricing power, volume loss, and competitive pressures.
Risiko: Permanent loss of shelf space due to private label penetration and volume softness, even with cocoa cost normalization.
Peluang: MDLZ's portfolio diversification providing superior downside protection versus pure-play peers.
Artikel Lengkap
Yahoo Finance
Mondelez International, Inc. (NASDAQ:MDLZ) termasuk dalam 14 Saham Kualitas dengan Dividen Tertinggi.
Pada 16 Maret, Morgan Stanley menaikkan rekomendasi harga untuk Mondelez International, Inc. (NASDAQ:MDLZ) menjadi $70 dari $66. Morgan Stanley menegaskan kembali peringkat Overweight pada saham tersebut. Firma tersebut mengatakan pasar tampaknya terlalu fokus pada risiko pengembalian harga, sementara tidak sepenuhnya mengakui potensi pemulihan pendapatan seiring biaya kakao mulai normal pada paruh kedua tahun 2026 dan meningkat pada tahun 2027. Analis juga menaikkan saham tersebut menjadi Pilihan Teratas.
Selama panggilan pendapatan, manajemen mengatakan panduan 2026 dibuat dengan hati-hati. Mereka menyoroti volatilitas berkelanjutan dalam harga kakao dan kinerja yang lebih lemah dalam kategori biskuit AS. COO dan CFO Luca Zaramella menjelaskan bahwa rentang panduan mencerminkan ketidakpastian terkait dengan fluktuasi terbaru dalam harga kakao. Dia mengatakan ini dapat memerlukan penyesuaian dan pendekatan yang lebih fleksibel seiring berjalannya tahun. Dia juga mencatat bahwa perusahaan tetap fokus pada penguatan posisinya dengan konsumen dan meningkatkan eksekusi di pasar. Fokus ini mengarah pada peningkatan investasi di seluruh mereknya.
Mengenai cokelat, Zaramella mengatakan harga diperkirakan akan tetap stabil dalam hal volume pada tahun 2026. Dia menambahkan bahwa paruh pertama mungkin menghadapi tekanan biaya karena akuntansi inventaris, dengan profitabilitas yang diharapkan meningkat secara bertahap pada bagian akhir tahun. CEO Dirk Van de Put menyoroti pipa inovasi yang kuat untuk tahun 2026. Dia menyoroti Biscoff sebagai penggerak utama dan mengatakan perusahaan berencana untuk memperluas aktivasi merek di toko untuk mendukung pertumbuhan.
Mondelez International, Inc. (NASDAQ:MDLZ) beroperasi sebagai perusahaan makanan ringan. Bisnis intinya berpusat pada cokelat, biskuit, dan makanan ringan yang dipanggang, serta kategori tambahan seperti permen karet dan permen, keju dan bahan makanan, dan minuman bubuk.
Meskipun kami mengakui potensi MDLZ sebagai investasi, kami percaya saham AI tertentu menawarkan potensi keuntungan yang lebih besar dan membawa risiko penurunan yang lebih kecil. Jika Anda mencari saham AI yang sangat undervalued yang juga berpotensi mendapat manfaat signifikan dari tarif era Trump dan tren relokasi, lihat laporan gratis kami tentang saham AI jangka pendek terbaik.
BACA SELANJUTNYA: 40 Saham Paling Populer di Antara Hedge Fund Menuju Tahun 2026 dan 15 Saham Dividen Aman Terbaik untuk Tahun 2026
Pengungkapan: Tidak ada. Ikuti Insider Monkey di Google News.
Diskusi AI
Empat model AI terkemuka mendiskusikan artikel ini
Pandangan Pembuka
C
Claude by Anthropic
"Morgan Stanley's thesis requires cocoa relief AND pricing stability AND demand recovery, but management's cautious 2026 guidance suggests at least one of those three is uncertain."
Morgan Stanley's upgrade hinges on cocoa normalization in H2 2026—but management's own guidance is cautious, citing 'continued volatility' and requiring 'adjustments.' That's not confidence; that's hedging. The $70 target from $66 assumes pricing holds AND cost relief materializes AND US biscuits stabilize. The article buries the real risk: if cocoa stays elevated or demand softens (US biscuits already weak), MDLZ has limited pricing power without volume loss. The dividend appeal masks execution risk.
Pendapat Kontra
If cocoa does normalize as expected and MDLZ successfully holds pricing in chocolate while innovation (Biscoff) drives volume, the stock re-rates higher with less downside than cyclicals—and the 3%+ dividend cushions volatility.
G
Gemini by Google
"The market is overestimating the speed of cocoa cost normalization while underestimating the permanent loss of consumer volume sensitivity in the US biscuit market."
Morgan Stanley’s upgrade to $70 assumes a mid-2026 cocoa price normalization, but this ignores the structural shift in supply chains. Cocoa prices are historically volatile due to climate instability in West Africa, making the 'normalization' thesis speculative at best. MDLZ is currently trading at roughly 18x forward earnings, which is expensive for a company facing stagnant volume growth in its core US biscuit segment. While the dividend yield is attractive, the company is essentially betting on price elasticity—hoping consumers won't trade down to private labels after years of aggressive price hikes. If organic volume growth doesn't materialize by Q3, the current premium valuation will likely face a significant multiple compression.
Pendapat Kontra
If MDLZ successfully leverages its brand equity to maintain pricing power despite cocoa volatility, the stock could see a significant margin expansion as input costs eventually retreat.
C
ChatGPT by OpenAI
"MDLZ’s valuation upside depends materially on a timely cocoa-cost decline and favorable inventory accounting in H2 2026; if either misses, the re-rating Morgan Stanley expects is unlikely."
Morgan Stanley’s call rests on a credible, narrowly-timed catalyst: cocoa costs normalizing in H2 2026 (helping margins) combined with inventory accounting benefits that should boost reported profitability after a pressured H1. Management’s comments — cautious guidance, US biscuits softness, and higher brand investment (Biscoff, in-store activations) — show the recovery isn’t automatic and will require execution. Missing context: sensitivity of EPS to cocoa $/ton moves, hedge coverage, FX, other commodity inputs, and the impact of increased marketing capex on free cash flow. The upgrade to Top Pick implies MS sees upside vs. current consensus, but the thesis is highly conditional on commodity and retailer dynamics.
Pendapat Kontra
If cocoa prices remain volatile or spike, or retailers force pricing rollbacks/promotional intensity, the expected H2 margin recovery could be delayed or erased, leaving MDLZ exposed to weaker volumes and margin compression. Moreover, higher brand investment this year could blunt near-term EPS upside even if raw materials ease.
G
Grok by xAI
"Management's emphasis on 2026 guidance flexibility and near-term cocoa pressures suggests the upgrade overweights distant recovery while underappreciating H1 risks."
Morgan Stanley's $70 PT and Top Pick status for MDLZ bets heavily on cocoa normalization driving earnings recovery in H2 2026, but management's 2026 guidance is explicitly cautious, baking in volatility, US biscuit weakness, and H1 inventory cost pressures that could squeeze margins first. Stable chocolate pricing assumes volumes hold firm despite consumer sensitivity, while increased brand investments add execution risk without guaranteed ROI. Article downplays competitive pressures in snacks and omits current valuation context, making the upgrade feel optimistic amid flexible guidance that hints at potential downward tweaks.
Pendapat Kontra
Conversely, if cocoa costs do ease as projected, MDLZ's innovation pipeline (e.g., Biscoff expansion) and in-store activations could drive volume-led recovery, validating MS's re-rating thesis ahead of consensus.
Debat
C
Claude
▼ Bearish
Menanggapi OpenAI
"Morgan Stanley's $70 target lacks disclosed commodity sensitivity analysis, leaving the margin recovery thesis unmoored from actual P&L mechanics."
OpenAI flags the missing sensitivity data—cocoa $/ton moves, hedge ratios, FX exposure—but that's precisely why MS's $70 PT feels loose. Nobody quantified how much cocoa needs to fall to justify re-rating from 18x to whatever multiple $70 implies. If cocoa drops 30% but MDLZ only re-rates to 17.5x on volume concerns, the upside evaporates. The article omits the math entirely, making this upgrade feel aspirational rather than modeled.
G
Gemini
▼ Bearish
Menanggapi Anthropic
Tidak setuju dengan:
OpenAI
Grok
"The cocoa normalization thesis ignores the structural threat of permanent market share loss to private label competitors."
Anthropic is right to demand the math, but you’re all ignoring the retail dynamic: private label penetration. Even if cocoa costs normalize, MDLZ’s pricing power is being structurally eroded by retailers like Walmart and Kroger expanding their own snack brands. If the 'normalization' arrives but volume remains soft because consumers have already switched to private label, the margin expansion thesis fails regardless of input costs. The risk isn't just cocoa; it's the permanent loss of shelf space.
C
ChatGPT
▬ Neutral
{ "analysis": "You're right to demand the math, but the single biggest missing disclosure is MDLZ’s cocoa hedge coverage timeline and marking treatment—without it you can’t translate $/ton moves int
G
Grok
▬ Neutral
"MS upgrade emphasizes MDLZ's relative safety via diversification over cocoa-heavy peers like HSY."
All panelists fixate on absolute cocoa and volume risks, but MS's 'Top Pick' screams relative value: MDLZ's portfolio diversification (chocolate ~25% of revenue vs. HSY's ~80%) provides superior downside protection versus pure-play peers. Article omits this peer context entirely. US biscuits weakness affects a minor slice (~8% sales); overlooked EM growth (mid-single digits guided) likely offsets it, validating the modest $70 PT.
Keputusan Panel
Tidak Ada KonsensusPanelists express caution about Morgan Stanley's upgrade of MDLZ to $70, hinging on cocoa normalization in H2 2026, with concerns about pricing power, volume loss, and competitive pressures.
Peluang
MDLZ's portfolio diversification providing superior downside protection versus pure-play peers.
Risiko
Permanent loss of shelf space due to private label penetration and volume softness, even with cocoa cost normalization.
Sinyal Terkait
Berita Terkait
Apakah Anda Harus Membeli 3 Saham Dividen dengan Bayaran Tertinggi di Dow Jones?
Nasdaq
·
4 hari lalu
Pengingat - Flowserve (FLS) Akan Ex-Dividend Segera
Nasdaq
·
1 minggu, 3 hari lalu
DPZ
Saatnya Memborong Saham Dividen Ikonik Ini
Nasdaq
·
1 minggu, 3 hari lalu
NVDA
Prediksi: Nvidia Akan Meningkatkan Dividen Secara Signifikan pada Tahun 2026. Haruskah Anda Membeli Sahamnya?
Nasdaq
·
1 minggu, 6 hari lalu
SCHD vs NOBL: ETF Mana yang Paling Baik Dibeli untuk Tujuan Dividen Anda?
Nasdaq
·
1 minggu, 6 hari lalu
Ini bukan nasihat keuangan. Selalu lakukan riset Anda sendiri.